<DOC>
	<DOCNO>NCT02052622</DOCNO>
	<brief_summary>To investigate long-term safety maintenance efficacy ATX-101 reduction submental fat</brief_summary>
	<brief_title>Long-term Follow-up Study Safety Maintenance Efficacy ATX-101</brief_title>
	<detailed_description>In study , patient complete randomized , double-blind , placebo-controlled phase 3 study ATX-101-10-16 ATX-101-10-17 recruited German study sit followed-up 2 year . No study medication administer study .</detailed_description>
	<criteria>Signed write informed consent studyrelated activity carry Any subject successfully complete final visit ( visit 7 ) phase 3 clinical trial , ATX1011016 ATX1011017 reduction submental fat , i.e . subject must least one study treatment administer complete predecessor study visit 7 Willingness comply schedule procedure study Subjects , since completion prior phase 3 study ATX1011016 ATX1011017 , undergo treatment may affect evaluation submental area ( e.g . limited longterm treatment systemic corticosteroid , liposuction , surgery lipolytic treatment submental area , treatment radio frequency , laser procedure , chemical peel , dermal filler neck chin area botulinum toxin injection neck chin area )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>submental fat reduction</keyword>
</DOC>